Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
可溶性 ST2 是否可以作为 TAVR 患者肺动脉高压风险评估的潜在生物标志物？
期刊:Life-Basel
影响因子:
doi:10.3390/life12030389
Elke Boxhammer, Moritz Mirna, Laura Bäz, Nina Bacher, Albert Topf, Brigitte Sipos, Marcus Franz, Daniel Kretzschmar, Uta C Hoppe, Alexander Lauten, Michael Lichtenauer
